REGULATED PRESS RELEASE published on 04/01/2026 at 18:00, 7 months 7 days ago Financial statements - 31 december 2025 EXACOMPTA CLAIREFONTAINE Board of Directors reviewed and approved 2025 financial statements, highlighting revenue and operating income figures. Economic conditions and outlook also discussed Financial Statements Revenue Operating Income Exacompta Clairefontaine Economic Conditions
BRIEF published on 03/26/2026 at 18:05, 7 months 13 days ago EXACOMPTA CLAIREFONTAINE: 2025 Review and 2026 Forecast Revenue Stationery Market Energy Costs Outlook 2026 Operational Result
BRIEF published on 03/26/2026 at 18:05, 7 months 13 days ago EXACOMPTA CLAIREFONTAINE : Bilan 2025 et Prévisions pour 2026 Chiffre D'affaires Résultat Opérationnel Marché Papeterie Coûts Énergétiques Perspectives 2026
REGULATED PRESS RELEASE published on 03/26/2026 at 18:00, 7 months 13 days ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026 Résumé des résultats financiers et perspectives d'Exacompta Clairefontaine pour 2025 et 2026 Résultats Financiers Assemblée Générale Dividende Perspectives Exacompta Clairefontaine
BRIEF published on 01/07/2026 at 18:05, 10 months 1 day ago Exacompta Clairefontaine : Droits de Vote et Actions en 2025 Droits De Vote Capital Social Actions Exacompta Clairefontaine Autocontrôle
BRIEF published on 01/07/2026 at 18:05, 10 months 1 day ago Exacompta Clairefontaine: Voting Rights and Shares in 2025 Share Capital Voting Rights Actions Exacompta Clairefontaine Self-monitoring
REGULATED PRESS RELEASE published on 01/07/2026 at 18:00, 10 months 1 day ago Droits de vote et actions 2025 Déclaration du nombre total de droits de vote et d'actions composant le capital de la société EXACOMPTA CLAIREFONTAINE au cours de l'année 2025 Capital Déclaration Droits De Vote Actions Exacompta Clairefontaine
REGULATED PRESS RELEASE published on 10/01/2025 at 18:15, 1 year 1 month ago Financial statements - 30 june 2025
BRIEF published on 09/23/2025 at 18:20, 1 year 1 month ago EXACOMPTA CLAIREFONTAINE Reports Decrease in H1 2025 Profits Financial Results Market Challenges Revenue Decline Operating Income Management Changes
Published on 11/06/2026 at 22:15, 2 days 10 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 20 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 20 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 20 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 09:00, 12 minutes ago Cantourage further develops Telecan and strengthens digital access to medical care
Published on 11/09/2026 at 09:00, 12 minutes ago Municipality Finance issues a GBP 50 million tap under its MTN programme
Published on 11/09/2026 at 09:00, 12 minutes ago Municipality Finance issues EUR 47.5 million zero coupon notes under its MTN programme
Published on 11/09/2026 at 09:00, 13 minutes ago Original-Research: EBRO MOTORS GROUP EV SA (von NuWays AG): BUY
Published on 11/09/2026 at 07:00, 2 hours 13 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 2 hours 13 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 2 hours 13 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 2 hours 13 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 14 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
